Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?

Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?

Item
http://www.wikidata.org/entity/Q38378364
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.Cutaneous Metastasis of Neuroendocrine Carcinoma with Unknown Primary Site: Case Report and Review of the Literature.Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements.The Added Diagnostic Value of 18F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.UEG Week 2015 Poster Presentations
P2860

Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?

Item
http://www.wikidata.org/entity/Q38378364
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
type
label
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
prefLabel
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698